40803 recent Wall Street rating changes — with our own star rating shown next to every analyst we independently track.
Track the latest analyst rating changes from Wall Street brokerages: stock upgrades, downgrades and price-target revisions, updated through the day. Unlike a plain ratings feed, every change here is matched — where we can — to the analyst's independent track record on 13Foresight, so you can see at a glance whether the person behind the call has actually been accurate. Analysts we rank show a ★★★★☆ score and link to their full performance page; firms link to their pooled track record. Use the tabs below to filter by change type.
| When | Stock | Change | Analyst | Rating | Price Target |
|---|---|---|---|---|---|
|
Sep 09
18:58 UTC
|
BRZE
Braze
|
◎ Target | Alexei Gogolev ★★★☆☆ #1221 | Overweight | $35.00→ $34.00-2.9% |
|
Sep 09
18:58 UTC
|
BRZE
Braze
|
◎ Target | Taylor McGinnis ★★★★★ #41 | Buy | $28.00→ $32.00+14.3% |
|
Sep 09
18:58 UTC
|
BRZE
Braze
|
◎ Target | Brian Peterson ★★★☆☆ #1387 | Outperform | $27.00→ $33.00+22.2% |
|
Sep 09
18:58 UTC
|
BRZE
Braze
|
◎ Target | David Hynes ★★★★★ #172 | Buy | $35.00→ $37.00+5.7% |
|
Sep 09
18:58 UTC
|
BBOT
BridgeBio Oncology Therapeutics
|
◎ Target | Sean McCutcheon ★★☆☆☆ #2276 | Outperform | $24.00→ $22.00-8.3% |
|
Sep 09
18:58 UTC
|
BBOT
BridgeBio Oncology Therapeutics
|
◎ Target | John Newman ★★☆☆☆ #2526 | Buy | $23.00→ $20.00-13.0% |
|
Sep 09
17:58 UTC
|
UCB
United Community Banks
|
◎ Target | Stephen Scouten ★★★★☆ #780 | Neutral | $37.00→ $38.00+2.7% |
|
Sep 09
17:58 UTC
|
GEMI
Gemini Space Station
|
◎ Target | James Yaro ★★★☆☆ #1393 | Sell | $3.50→ $4.00+14.3% |
|
Sep 09
17:58 UTC
|
ETOR
eToro Group
|
◎ Target | James Yaro ★★★☆☆ #1393 | Neutral | $32.00→ $36.00+12.5% |
|
Sep 09
17:58 UTC
|
DYN
Dyne Therapeutics
|
◎ Target | Michael Ulz ★☆☆☆☆ #3014 | Overweight | $45.00→ $36.00-20.0% |
|
Sep 09
17:58 UTC
|
COIN
Coinbase Global
|
◎ Target | James Yaro ★★★☆☆ #1393 | Buy | $196.00→ $219.00+11.7% |
|
Sep 09
17:58 UTC
|
CHYM
Chime Financial
|
◎ Target | Timothy Chiodo ★★★★★ #311 | Neutral | $28.00→ $31.00+10.7% |
|
Sep 09
17:58 UTC
|
CHYM
Chime Financial
|
◎ Target | James Faucette ★★★☆☆ #1219 | Overweight | $39.00→ $40.00+2.6% |
|
Sep 09
17:58 UTC
|
CHYM
Chime Financial
|
◎ Target | Patrick Moley ★★★☆☆ #2197 | Overweight | $35.00→ $40.00+14.3% |
|
Sep 09
17:58 UTC
|
ABM
ABM Industries
|
◎ Target | Joshua Chan ★★★☆☆ #1374 | Neutral | $45.00→ $51.50+14.4% |
|
Sep 09
16:58 UTC
|
PHVS
Pharvaris
|
◎ Target | Joseph Schwartz ★★★☆☆ #2153 | Outperform | $50.00→ $65.00+30.0% |
|
Sep 09
16:58 UTC
|
MRK
Merck & Co., Inc.
|
◎ Target | Daina Graybosch ★★★☆☆ #1370 | Outperform | $127.00→ $161.00+26.8% |
|
Sep 09
16:58 UTC
|
EVMN
Evommune
|
◎ Target | Thomas Smith ★★☆☆☆ #2808 | Outperform | $28.00→ $22.00-21.4% |
|
Sep 09
16:58 UTC
|
BXP
BXP
|
◎ Target | Michael Lewis ★★★☆☆ #1431 | Hold | $64.00→ $68.00+6.2% |
|
Sep 09
15:58 UTC
|
TTAN
ServiceTitan
|
◎ Target | Parker Lane not yet tracked | Buy | $125.00→ $100.00-20.0% |
|
Sep 09
15:58 UTC
|
RVMD
Revolution Medicines
|
◎ Target | Laura Prendergast ★★☆☆☆ #2769 | Buy | $215.00→ $230.00+7.0% |
|
Sep 09
15:58 UTC
|
PYXS
Pyxis Oncology
|
◎ Target | Derek Archila ★★★☆☆ #2252 | Overweight | $12.00→ $19.00+58.3% |
|
Sep 09
15:58 UTC
|
PAYX
Paychex
|
◎ Target | David Grossman ★★★★★ #98 | Hold | $110.00→ $130.00+18.2% |
|
Sep 09
15:58 UTC
|
JILL
J.Jill
|
◎ Target | Janine Stichter ★★★☆☆ #1299 | Buy | $18.00→ $25.00+38.9% |
|
Sep 09
15:58 UTC
|
BBOT
BridgeBio Oncology Therapeutics
|
◎ Target | Laura Prendergast ★★☆☆☆ #2769 | Buy | $23.00→ $15.00-34.8% |
|
Sep 09
15:58 UTC
|
ADBE
Adobe
|
◎ Target | Parker Lane not yet tracked | Hold | $200.00→ $225.00+12.5% |
|
Sep 09
14:58 UTC
|
ZWS
Zurn Elkay Water Solutions Cor
|
◎ Target | Bryan Blair ★★★☆☆ #1449 | Outperform | $58.00→ $60.00+3.4% |
|
Sep 09
14:58 UTC
|
VALE
Vale
|
◎ Target | Bob Brackett ★★★☆☆ #1421 | Market Perform | $12.00→ $12.50+4.2% |
|
Sep 09
14:58 UTC
|
TTAN
ServiceTitan
|
◎ Target | Michael Turrin ★★★☆☆ #972 | Overweight | $115.00→ $105.00-8.7% |
|
Sep 09
14:58 UTC
|
TTAN
ServiceTitan
|
◎ Target | Andrew Sherman ★★★★★ #40 | Buy | $125.00→ $100.00-20.0% |
|
Sep 09
14:58 UTC
|
SYK
Stryker
|
◎ Target | Larry Biegelsen ★★★★☆ #783 | Overweight | $418.00→ $348.00-16.7% |
|
Sep 09
14:58 UTC
|
ROIV
Roivant Sciences
|
◎ Target | Yaron Werber ★★★☆☆ #2214 | Buy | $50.00→ $55.00+10.0% |
|
Sep 09
14:58 UTC
|
RIO
Rio Tinto
|
◎ Target | Bob Brackett ★★★☆☆ #1421 | Outperform | $88.50→ $89.50+1.1% |
|
Sep 09
14:58 UTC
|
RAL
Ralliant
|
◎ Target | Ian Zaffino ★★★☆☆ #1584 | Outperform | $75.00→ $80.00+6.7% |
|
Sep 09
14:58 UTC
|
QCOM
Qualcomm
|
◎ Target | Srini Pajjuri ★★★☆☆ #1655 | Sec→ r Perform | $160.00→ $180.00+12.5% |
|
Sep 09
14:58 UTC
|
PHVS
Pharvaris
|
◎ Target | Yanan Zhu ★★★☆☆ #2248 | Overweight | $55.00→ $65.00+18.2% |
|
Sep 09
14:58 UTC
|
PAYX
Paychex
|
◎ Target | Jason Kupferberg ★★★★☆ #874 | Underweight | $95.00→ $111.00+16.8% |
|
Sep 09
14:58 UTC
|
ORA
Ormat Technologies
|
◎ Target | Noah Kaye ★★☆☆☆ #2278 | Outperform | $141.00→ $145.00+2.8% |
|
Sep 09
14:58 UTC
|
NEM
Newmont
|
◎ Target | Bob Brackett ★★★☆☆ #1421 | Outperform | $147.00→ $144.00-2.0% |
|
Sep 09
14:58 UTC
|
LOW
Lowe's Companies
|
◎ Target | Zhihan Ma ★★★★☆ #518 | Outperform | $261.00→ $254.00-2.7% |
|
Sep 09
14:58 UTC
|
KNF
Knife River
|
◎ Target | Timna Tanners ★★★☆☆ #1883 | Equal Weight | $73.00→ $62.00-15.1% |
|
Sep 09
14:58 UTC
|
IONQ
IonQ
|
◎ Target | Vijay Rakesh ★★★☆☆ #2200 | Outperform | $61.00→ $52.00-14.8% |
|
Sep 09
14:58 UTC
|
IEX
IDEX
|
◎ Target | Bryan Blair ★★★☆☆ #1449 | Outperform | $265.00→ $270.00+1.9% |
|
Sep 09
14:58 UTC
|
HOOD
Robinhood Markets
|
◎ Target | Dan Dolev ★★★☆☆ #2021 | Outperform | $130.00→ $140.00+7.7% |
|
Sep 09
14:58 UTC
|
HD
Home Depot
|
◎ Target | Zhihan Ma ★★★★☆ #518 | Market Perform | $354.00→ $344.00-2.8% |
|
Sep 09
14:58 UTC
|
HASI
HA Sustainable Infrastructure Capital
|
◎ Target | Maheep Mandloi ★☆☆☆☆ #3089 | Outperform | $41.00→ $50.00+22.0% |
|
Sep 09
14:58 UTC
|
FCX
Freeport-McMoRan
|
◎ Target | Bob Brackett ★★★☆☆ #1421 | Market Perform | $50.00→ $47.00-6.0% |
|
Sep 09
14:58 UTC
|
CRH
CRH
|
◎ Target | Timna Tanners ★★★☆☆ #1883 | Overweight | $132.00→ $107.00-18.9% |
|
Sep 09
14:58 UTC
|
BLTE
Belite Bio
|
◎ Target | Graig Suvannavejh ★★☆☆☆ #2663 | Outperform | $220.00→ $234.00+6.4% |
|
Sep 09
14:58 UTC
|
B
Barrick Mining
|
◎ Target | Bob Brackett ★★★☆☆ #1421 | Outperform | $61.00→ $56.50-7.4% |
An analyst rating change is when a Wall Street brokerage updates its recommendation on a stock — an upgrade (e.g. Hold → Buy), a downgrade (e.g. Buy → Sell), or a price-target revision (raising or lowering the expected share price). This page lists the most recent changes across U.S. markets.
Where we independently track the analyst, each change shows our own star rating and accuracy rank, computed from real historical price performance — not the brokerage's own marketing. That lets you judge whether the analyst behind a call has actually been right before.
The feed refreshes several times a day, so new upgrades, downgrades and price-target changes appear the same day they are published. Each row shows the date and time we recorded it.
No. A rating change is one analyst's opinion, not investment advice. Track records vary widely — which is exactly why we attach each analyst's independent accuracy. Always do your own research.